Nuvectis Pharma, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.62 | $56.28 M | -5.86 | 2 | $0 |
![]() AVTE
Aerovate Therapeutics, Inc. |
$2.70 | $597.48 M | -6.84 | 30 | $0 |
![]() CCCC
C4 Therapeutics, Inc. |
$4.09 | $320.64 M | -1.97 | 110 | $20.76 M |
![]() CELC
Celcuity Inc. |
$13.17 | $501.59 M | -5.14 | 55 | $0 |
![]() CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
![]() CMPX
Compass Therapeutics, Inc. |
$1.58 | $180.24 M | -3.74 | 35 | $0 |
![]() CNTA
Centessa Pharmaceuticals plc |
$16.74 | $884.24 M | -6.2 | 75 | $6.85 M |
![]() DBTX
Decibel Therapeutics, Inc. |
$4.91 | $123.37 M | -1.93 | 68 | $0 |
![]() ELYM
Eliem Therapeutics, Inc. |
$5.11 | $258.33 M | -17.08 | 9 | $0 |
![]() EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() GOSS
Gossamer Bio, Inc. |
$1.09 | $124.06 M | -0.65 | 135 | $0 |
![]() HOWL
Werewolf Therapeutics, Inc. |
$1.62 | $151.66 M | -3.17 | 46 | $1.89 M |
![]() IKNA
Ikena Oncology, Inc. |
$1.66 | $84.45 M | -1.11 | 14 | $0 |
![]() IVA
Inventiva S.A. |
$2.20 | $185.39 M | -1.34 | 123 | $17.48 M |
![]() KRON
Kronos Bio, Inc. |
$0.97 | $44.62 M | -0.37 | 62 | $6.29 M |
![]() LRMR
Larimar Therapeutics, Inc. |
$3.96 | $611.84 M | -9.99 | 42 | $0 |
![]() LYRA
Lyra Therapeutics, Inc. |
$0.22 | $19.53 M | -0.27 | 88 | $1.53 M |
![]() NAMS
NewAmsterdam Pharma Company N.V. |
$25.85 | $1.74 B | -7.15 | 68 | $45.56 M |
![]() OBIO
Orchestra BioMed Holdings, Inc. |
$5.66 | $285.59 M | -5.47 | 56 | $2.76 M |
![]() OLMA
Olema Pharmaceuticals, Inc. |
$5.50 | $734.41 M | -6.56 | 87 | $0 |
![]() REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |